Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sector of biopharmaceuticals, giving promising improvements throughout various professional medical and industrial applications. With its structural similarity to The natural way derived human serum albumin, OsrHSA delivers a safer, much more trusted substitute